News & Perspective

Sep 20, 2012

Sep 20, 2012

ECDC studies shed new light on narcolepsy and H1N1 vaccine

(CIDRAP News) – The European Centre for Disease Prevention and Control (ECDC) today confirmed a link between narcolepsy and pandemic 2009 H1N1 vaccination in children in Finland and Sweden, the two countries that originally reported a problem with the vaccine.

Mar 21, 2011

Mar 21, 2011

Preliminary studies show lower flu-shot effectiveness in Europe

(CIDRAP News) – Preliminary studies suggest that this year's trivalent seasonal flu vaccine used in Europe was less effective against the 2009 H1N1 virus than last year's monovalent H1N1 vaccine was, possibly because of some degree of mutation in the virus, according to recent reports in Eurosurveillance.

Feb 21, 2011

Feb 21, 2011

Flu activity shows signs of receding in Europe

(CIDRAP News) – Influenza activity persists at medium to high levels in most European Union countries but is showing signs of decreasing, according to the latest report from the European Centre for Disease Prevention and Control (ECDC).

Jan 11, 2011

Jan 11, 2011

European study says H1N1 vaccine offered good protection

(CIDRAP News) – In the largest study of its kind so far to assess how well 2009 H1N1 vaccines performed in the pandemic setting, new findings from seven European countries showed they provided good protection, a result that mirrors early clinical studies.

Feb 03, 2009

Feb 03, 2009

Experts weigh new H5N1 vaccine strategies

(CIDRAP News) – At an Infectious Diseases Society of America (IDSA) symposium in Washington, DC, today on seasonal and pandemic influenza, a group of experts fielded questions from reporters on some of the new trends and emerging issues, including prepandemic strategies for H5N1 avian influenza vaccines, now that some countries are stockpiling them.

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»